Schedule

This program is among the highest-rated Harvard Medical School CME courses. 

All agenda sessions are in Eastern Time.

Please note that program changes/substitutions may be made without notice.

Print Schedule
Day 1

Monday, May 4, 2026

Welcome and Introduction

Dr. A. Enrique Caballero

9:00-9:15 am

Type 1 Diabetes: What Is New?

Screening, Diagnosis, and Staging of the Disease


9:15-9:40 am

Prevention and Treatment of Type 1 Diabetes: An Update


9:40-10:05 am

Panel Discussion and Practical Recommendations


10:05-10:45 am

Break

10:45-11:00

Lifestyle Modification in Diabetes, Obesity, and Related Disorders

What Do I Tell My Patient to Eat?


11:00-11:25 am

Get the Patient Moving! Exercise Recommendations


11:25-11:50 am

Panel Discussion and Practical Recommendations


11:50 am-12:30 pm

Break

12:30-1:20 pm

Incorporating Technological Advances in Diabetes Care

Continuous Glucose Monitoring: For Everyone with Diabetes?


1:20-1:45 pm

Is There a Role in for People with Prediabetes or Normal Glucose Levels?


1:45-2:10 pm

Panel Discussion and Practical Recommendations


2:10-2:50 pm

Break

Special Lecture

The Past, Present, and Future of Diabetes Care


3:00-3:45 pm

Day 2

Tuesday, May 5, 2026

Welcome, Recap, and Introduction to Day 2


9:00-9:10 am

Obesity as the Focus for the Prevention and Treatment of Diabetes and Related Disorders

Understanding Overweight and Obesity as a Disease


9:10-9:40 am

Obesity and Cancer: Are They Truly Related?


9:40-10:10 am

Obesity and Arthritis: Is It Just More Weight on the Joints?

10:10-10:50 am

Break

10:50-11:05 am

The Emotional and Psychological Impact of Obesity

11:05-11:35 am

Panel Discussion and Practical Recommendations


11:35 am-12:15 pm

Break

12:15-1:05 pm

Prevention and Treatment of Obesity: A Hot Debate

Pharmacological Management of Obesity


1:05-1:45 pm

Surgical Management of Obesity


1:45-2:30 pm

Q and A and Practical Recommendations


2:30-3:00 pm

Special Lecture

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2026 Vision


3:00-3:45 pm

Day 3

Wednesday, May 6, 2026

Welcome, Recap of Day 2 and Introduction to Day 3


9:00-9:10 am

Cardiovascular Disease in the Patient with Diabetes

Evaluating Cardiovascular Risk: The Role of CRP, Lp(a), Apo B and Calcium Scores


9:10-9:40 am

Evaluation and Management of Congestive Heart Failure


9:40-10:10 am

Q and A and Practical Recommendations


10:10-10:45 am

Break

10:45-11:00 am

Hypertension and Dyslipidemia Management in the Patient with Diabetes

Hypertension: Evaluation, Goals, and Current Treatment Recommendations


11:00-11:25 am

Dyslipidemia: Targets and Management Guidelines


11:25-11:50 am

Q and A and Practical Recommendations


11:50 am-12:30 pm

Break

12:30-1:20 pm

Chronic Kidney Disease in Diabetes and Metabolic Care

The Need to Thoroughly Evaluate Kidney Function: Why and How?


1:20-1:50 pm

Treatment of Chronic Kidney Disease: What Do the Guidelines Say?


1:50-2:20 pm

Q and A and Practical Recommendations


2:20-2:50 pm

Break

2:50-3:00 pm

Special Lecture

Artificial Intelligence in Diabetes Care: Fact or Fiction?

3:00-3:45 pm

Day 4

Thursday, May 7, 2026

Welcome, Recap of Day 3, and Introduction to Day 4


9:00-9:10 am

Improving Diabetes Care in the Trenches

What We All Can Do to Improve the Lives of Everyone with the Disease

Opportunities to Improve Diabetes Care in Your Community


9:10-9:40 am

Question and Answer Session


9:40-10:10 am

Pharmacological Management of Diabetes: Traditional Medications

Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)


10:10-10:40 am

Break

10:40-10:55 am

Insulin Therapy in the Patient with Diabetes


10:55-11:25 am

Q and A and Practical Recommendations


11:25 am-12:00 pm

Break

12:00-1:00 pm

Pharmacological Management of Type 2 Diabetes: SGLT-2 Inhibitors and GLP-1-Based Therapies

Perspectives from Different Medical Specialties

SGLT-2 Inhibitors: An Update from a Cardiologist's Perspective


1:00-1:35 pm

GLP-1 Receptor Agonists: An Update from an Obesity/Diabetes Perspective


1:35-2:10 pm

Mineralocorticoid Receptor Antagonists: An Update from a Nephrologist's Perspective


2:10-2:45 pm

Q and A and Practical Recommendations


2:45-3:00 pm

Closing Remarks

3:30-3:40 pm